glp-1 small molecule In the ACHIEVE-1 phase 3 trial, the oral small-molecule receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes A novel approach to exploit

Taylor & Francis Online

This makes adhering to the treatment plan simpler and increases the compliance of patients who are taking care of their diabetes, providing a sustained therapeutic effect with fewer doses

It suppresses glucagon, a hormone prompting glucose production in the liver, thereby minimizing excess glucose levels

In: Cadmium toxicity and tolerance in plants

Depletion of GSH as a consequence of acetaminophen toxicity to the liver has attracted the most attention in the medical scientific community, as it can frequently be fatal or require a liver transplant or emergency treatment to prevent liver failure (the liver is the organ with the greatest concentration of GSH)

Int J Mol Sci (2020) 21:6001